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Purpose: To demonstrate relationship between herpes simplex virus (HSV) corneal latency 
and graft survival.
Methods: Prospective case control study. 28 recipient corneal buttons and donor cornea-scleral 
remnants were examined for HSV DNA with polymerase chain reaction (PCR). None of the 
recipient had a history of HSV infection. Serum samples of graft recipients were analyzed for 
the presence of anti-HSV IgG and IgM with enzyme-linked immunosorbent assay technique. All 
corneas were free of stromal scarring or epithelial defect before sampling and had an endothelial 
cell density of 2000 cells/mm2.
Results: In twenty three patients (82%) anti-HSV IgG was detected in serum. In none of the 
recipients anti-HSV IgM was positive. HSV DNA was positive in six out of twenty eight (21%) 
of the recipient corneal buttons and none of the donor cornea-scleral remnants. In eighteen-
months follow-up period three out of six (50%) HSV DNA positive and one out of twenty-two 
(4.5%) HSV DNA negative patients experienced late endothelial failure that was statistically 
signiﬁ  cantly different (p = 0.022).
Conclusion: Even without a history of HSV keratitis, presence of latent HSV virus in recipient 
cornea is an important risk factor for subsequent graft survival.
Keywords: herpes simplex virus, polymerase chain reaction, corneal latency, corneal graft 
survival
Introduction
Graft failure, deﬁ  ned as the irreversible loss of the central transparency of the trans-
planted cornea, is a frustrating experience for the patient and the surgeon. Irreversible 
rejection, glaucoma, infection, primary failure, late endothelial failure are some of the 
causes of graft failure. Late endothelial failure is deﬁ  ned as a gradual graft decom-
pensation without any history of a rejection episode and an apparent cause which is 
unresponsive to corticosteroids.
Herpes simplex virus (HSV) is a DNA virus that induces keratitis, uveitis, or 
retinitis in immunocompetent subjects. After invading cornea, virus established latency 
in trigeminal ganglion (Shimeld et al 1995) and can be reactivated by stimuli such as 
sunlight, emotional stress, fever, and corticosteroids usage (Beyer et al 1989).
Herpetic infection also involves corneal endothelial cells. Most common cause 
of graft failure in metaherpetic recipients is the HSV reactivation (Sterk et al 1995). 
HSV infection caused severe endothelial cell loss in corneal organ culture (Cleator 
et al 1994) and has been implicated in some cases of primary graft failure (Cleator et al 
1994; Cockerham et al 1997; De Kesel et al 2001). These evidences show that HSV 
might be the cause of some failures of corneal grafting.
The aim of our study was to establish whether the presence of HSV, as demon-
strated by polymerase chain reaction (PCR) in donor or recipient corneas in whom Clinical Ophthalmology 2007:1(2) 128
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no previous history of herpes simplex keratitis (HSK), could 
correlate with graft outcome over a 18-months period.
Material and method
The study adhered to the Declaration of Helsinki and 
Good Clinical Practice guidelines. The subjects were 
enrolled after Institutional Review Board approval. Written 
informed consent was taken from 28 recipients (12 males 
and 16 females; mean age 54 ± 16.2 years; age range 
24–73 years), who underwent corneal transplantation 
between 2001 and 2004 because of pseudophakic bullous 
keratopathy (9 patients), keratoconus (7 patients), corneal 
dystrophy (4 patients), corneal opacity due to trauma 
(4 patients), alkali burns (2 patients), and trachoma 
(2 patients) (Table 1). Written informed consent was 
taken from the families of cornea donors (14 males and 
14 females; mean age 31.9 ± 8.6; age range 19–48 years). 
None of the participants had a history of HSV infection. 
All corneas were free of stromal scarring or epithelial 
defect before sampling and had an endothelial cell density 
of 2000 cells/mm2. Donor corneal remnants and recipient 
corneal buttons were preserved in a clot tube at −80 °C for 
polymerase chain reaction (PCR) analysis.
HSV serology
An enzyme-linked immunosorbent assay (ELISA) technique 
was used to detect anti-HSV IgG and IgM in serum samples 
of graft recipients.
Tissue preparation and DNA extraction
The specimens were crushed in phosphate buffered saline, 
and then centrifuged at 13.000 rpm for 15 minute at 
20 °C. The pellets were left to stand in a digestion buffer 
containing 10 mM Tris-HCl, pH7.4, 100 mM NaCl, and 
25 mM EDTA, 0.5% sodium dodecyl sulfate (SDS), 
200 mg/ml of proteinase K for overnight at 37 °C (Shimizu 
and Burns 1995). After proteinase K inactivation, 0.5 ml of 
saturated phenol pH 8 was added. Tubes were centrifuged 
at 1500 g for 15 min, and supernatant was transferred 
to another tube. Then, phenol–chloroform–isoamyl 
alcohol (25:24:1 ratio) was added, and the microtubes 
were centrifuged at 1500 g for 15 min. Supernatant was 
then transferred to another tube and chloroform–isoamyl 
alcohol (24:1) was added and then centrifuged at 1500 g 
for 15 min. DNA was precipitated using absolute ethanol 
and ammonium acetate (7 M) at −20 °C overnight. The 
solution was centrifuged at 16,000 g for 20 min. After 
decanting the supernatant, the pellet was washed with 
70% ethanol and diluted with 20 μl sterile distilled water 
for PCR.
Ampliﬁ  cation
We used 50 μl of reaction mixture containing 2 U of Taq 
polymerase (Promega Corp., Madison, WI), 10 × PCR buffer 
(Tris-HCL 100 mM, pH 8.0; KCl 500 mM), 200 μM of 
deoxyribonucleotide triphosphate dATP, dTTP, dCTP, dGTP, 
for each and and 15 mM of MgCl2. A total of 500 ng of each 
DNA extract was then subjected to HSV PCR using speciﬁ  c 
primers KS30 (5ı-TTC AAG GCC ACC ATG TAC TAC AAA 
GACGT-3ı) and KS31 (5ı-GCC GTA AAA CGG GGA CAT 
GTA CAC AAA GT-3ı). Positive cases resulted in ampliﬁ  ca-
tion of a 431-bp fragment located on the HSV glycoprotein 
B gene. This target sequence is speciﬁ  c to HSV types 1 and 2 
and is known not to code for any other human herpesviruses. 
The PCR cycling conditions were pre-treatment at 94 °C for 
3 min, followed by 35–39 cycles of denaturation at 94 °C for 
1 min, annealing for 50 s, and extension at 72 °C 1 min fol-
lowed by an additional 7 min at 72 °C. Puriﬁ  ed DNA from 
HSV-1 McKrae strain of HSV-1 was used as a positive control, 
and sterile distilled water, replacing DNA, was used as a nega-
tive control. Amplicons of the expected size (431 bp) were 
visualized by electrophoresis with 2.0% agarose gel stained 
with ethidium bromide under ultraviolet light (Figure 1). The 
positive results double-checked by PCR.
Statistical analysis
Statistical analyses were carried out by employing the 
Statistical Package for Social Sciences software 11.0 for 
Windows package software (SPSS, Inc., Chicago, IL). The 
Fischer’s exact chi-square test was used and a p value less 
than 0.05 were considered as statistically signiﬁ  cant.
Figure 1 PCR with HSV KS30 primers (431 bp amplicon) were visualized by 
electrophoresis with 2.0% agarose gel stained with ethidium bromide under ultraviolet 
light. Lane 1 and 3 positive patient corneal specimens, lane 2 and 4 negative patient 
corneal specimens, lane 5 positive HSV McKrae strain control.Clinical Ophthalmology 2007:1(2) 129
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Results
Anti-HSV IgG was found in serum of twenty three patients 
(82%). Anti-HSV IgM was not detected in any. A positive 
test result in the HSV PCR was obtained in six out of twenty 
eight (21%) recipient corneal buttons and none of the donor 
cornea-scleral remnants. In the follow-up period four patients 
experienced late endothelial failure. In three of them HSV 
DNA were positive. Statistically signiﬁ  cant difference was 
present between HSV DNA positive corneas and HSV 
DNA negative corneas in respect to late endothelial failure 
(p = 0.022). Overall results are summarized in Table 1.
Discussion
Primary HSV infection usually occurs in childhood, and 
seroprevalence increase with age up to 85.3% in sexually 
active adults (Liesegang 2001; Dolar et al 2006).The HSV-1 
DNA was detected in trigeminal ganglion in 74 of 121 patients 
(61%) in a study (Motani et al 2006). Therefore, even 
without a history of HSV infection, all patients are probable 
carrier of latent HSV virus in trigeminal ganglia.
One of important cause of corneal opaciﬁ  cation is HSV 
keratitis in developing countries. Activation and centrifugal 
migration of latent virus from trigeminal ganglion is the 
pathogenesis of herpes simplex keratitis (HSK). HSV virus 
can also undergo latency and reactivation in the cornea as 
an extraneuronal site after HSK disease (Pavan-Langston 
et al 1989; Rong et al 1991). In previous studies HSV 
detection rate by PCR ranged from 32% to 82% in donor 
cornea buttons of subjects with a past history of herpes 
keratitis (Cantin et al 1991; van Gelderen et al 2000; Kaye 
et al 2000).
In corneas of clinically unsuspected herpetic keratitis 
patients HSV DNA was also isolated by PCR (Cantin et al 
1991; Kaye et al 2000). In different studies this rate was 
documented as 36% (Cantin et al 1991), and 22% (Kaye 
et al 2000). In our study we also demonstrated that six out 
of twenty eight (21%) corneal transplant patient without 
clinically obvious herpetic keratitis were carrying latent HSV 
virus in their corneas.
Recurrence of a herpetic infection following corneal 
transplantation is the main reason for graft failure in 
penetrating keratoplasties for HSK (Sterk et al 1995). It was 
shown that HSV infection cause severe endothelial cell loss 
(Cleator et al 1994) and HSV infection was suspected as the 
cause of some cases of primary graft failure (Cockerham et al 
1997; De Kesel et al 2001).
In patients with allograft failure without a history of HSK, 
an unexpected high number of HSV positive test results were 
found in recipient corneal buttons. Several stimuli related 
to corneal transplantation, such as surgical trauma, suture 
removal and immune reactions, the necessary application of 
local immunosuppression (Beyer et al 1989), may reactivate 
the virus. In these patients, no antiviral treatment was used 
since no obvious clinical signs of corneal HSV infection 
had been observed during the process of graft failure (Cook 
1992). In our study, three out of six HSV DNA positive 
recipients (50%) and one out of twenty-two DNA negative 
recipients (4.5%) experienced late endothelial failure that is 
statistically signiﬁ  cantly different.
Screening of donor cornea culture ﬂ  uid for HSV DNA, 
using PCR assay is not recommended. Only 3.8% of 
80 corneas were positive for HSV and post transplant fol-
low up of the three recipients revealed no evidence of HSV 
induced eye disease or primary graft failure (Morris et al 
1996). In our study we could not demonstrate HSV DNA 
by PCR in any of the recipient remnants.
In conclusion presence of latent HSV virus in recipient 
cornea is an important risk factor for subsequent graft out-
come. Therefore, even without a history of HSV keratitis, 
keratoplasty patient are at risk for graft failure due to HSV 
corneal latency.
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